Comparison

NAMI-A European Partner

Item no. TMO-T16266-500mg
Manufacturer TargetMol
CASRN 201653-76-1
Amount 500 mg
Quantity options 100 mg 10 mg 1 mg 200 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C5H10Cl4N2ORuS.C3H4N2.H
Smiles [H+].O=[S](C)(C)[Ru+3]([Cl-])([Cl-])([Cl-])([Cl-])[N]=1C=CNC1.N=1C=CNC1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias CETP
Shipping Condition Cool pack
Available
Manufacturer - Targets
FAK
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
458.18
Description
NAMI-A, a ruthenium-based compound, selectively targets tumor metastasis by inhibiting cancer cell adhesion and migration.
Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis|||Cytoskeletal Signaling
Bioactivity
NAMI-A is a ruthenium-based drug characterized by the selective activity against tumor metastases. NAMI-A inhibits adhesion and migration.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close